Dana Yaacov-Garbeli
Chief Financial OfficerMs. Dana Yaacov-Garbeli, C.P.A.,MBA, serves as Chief Financial Officer at Entera Bio Ltd. since June 2019. She was Principal Accounting Officer of Israel-based Entera Bio Ltd since June 2019 until July 2022. She served as Interim Chief Financial Officer at Entera Bio Ltd since June 2019 until November 2019. Ms. Yaacov-Garbeli is currently a Partner at A2Z Finance Ltd, where she serves as an outsourced Chief Financial Officer to both private and publicly traded companies and provides additional consulting and accounting services. She previously served as Senior Manager at PwC Israel overseeing audits of public and private companies. She had been Chief Financial Officer at Wilk Technologies Ltd (formerly known as Fantasy Network Ltd). since November 26, 2017 until January 04, 2022. She has extensive finance and accounting knowledge, including extensive expertise at a Big-4 accounting firm, PricewaterhouseCoopers. She has expertise in financial planning, operations, management and strategy expert in external and internal audit for public multinational clients under US GAAP, IFRS and PCAOB standards. She is currently a Partner at A2Z-Finance, where she served as an outsourced CFO to both private and publicly traded companies and provided additional consulting and accounting services. At PwC she served as the Lead Senior Manager on audits of both public and privately held multi-location companies in Israel, US and Europe, mainly in pharmaceuticals, biotech, holdings, industrial products and retail and high-tech sectors. Ms. Yaacov-Garbeli holds a B.A in accounting and business management and an MBA in financial management from The College of Management and Academic studies. Ms. Yaacov-Garbeli is a Certified Public Accountant in Israel.
Positions
- Company NameEntera Bio Ltd.Stock CodeENTXPositionChief Financial OfficerColleagues
- MJMiranda J. ToledanoCEO & Director
- GJGeno J. GermanoIndependent Chairman
- HGHillel GalitzerChief Operating Officer
- GBGregory BurshteinChief of Research & Development
- RBRachel B. WagmanChief Clinical Advisor
- FCFelicia CosmanChairman of Scientific Advisory Board & Chief Clinical Advisor (Endocrinology)
- HTHaya TaitelNon-Employee Independent Director
- SDSteven D. RubinIndependent Director
